Explore our market-ready, high-stability probiotic capsules, synbiotic gummies, and targeted digestive formulas engineered for rapid commercialization across global retail and pharmacy channels.
As a premier single-source OEM/ODM contract manufacturer with over 20 years of technical innovation, ORIZI Group operates 6 specialized companies across three integrated divisions. Our state-of-the-art biological manufacturing facilities are fully licensed and certified under JAKIM Halal, cGMP (Current Good Manufacturing Practice), ISO 13485 (Medical Device Standard), ISO 22000, HACCP, MDA, and SEDEX/SMETA global ethical audits. We empower over 1,000 global brand partners by delivering rigorous pharmaceutical-grade microencapsulated probiotic capsules, synbiotic powders, and functional health supplements.
Probiotic live microorganisms are exceptionally sensitive to ambient temperature, stomach gastric acidity, and atmospheric moisture. Standard capsule encapsulation frequently results in premature degradation before active bacteria reach the lower intestinal tract. ORIZI Group eliminates this technical vulnerability through proprietary Multi-Layer Enteric Microencapsulation & Nitrogen-Flushed Blister Packaging Technologies.
Our acid-resistant HPMC vegetable capsule shells utilize pH-triggered polymer matrix coatings that remain completely intact in gastric stomach acid (pH 1.2–2.0) and disintegrate precisely within the duodenal microbiome (pH 6.8+), guaranteeing over 98.5% live strain survival rate.
Humidity is the primary catalyst for cell lysis. We employ double-aluminum (Alu-Alu) cold-form foil blistering, desiccant sleeve bottles, and ultra-low RH (relative humidity < 20%) Class 100,000 cleanroom packaging to maintain verified CFU potency through a full 24-month shelf life.
Access our bio-bank containing over 5,000 validated probiotic, prebiotic, and postbiotic strains including Lactobacillus acidophilus, Bifidobacterium animalis subsp. lactis, Akkermansia muciniphila, and spore-forming Bacillus coagulans verified by 16S rRNA gene sequencing.
The international nutraceutical landscape is undergoing a structural transition from generic high-CFU digestive aids toward target-specific, clinical-grade synbiotics. B2B procurement directors, brand owners, and retail buyers must align their product portfolios with emerging consumer behaviors and scientific advancements to retain market share and secure high gross profit margins.
While live probiotics require strict cold-chain logistics or moisture barrier protection, heat-treated postbiotics (inactivated cells and cellular metabolites like short-chain fatty acids) offer extreme heat, acid, and mechanical stability. This allows OEM brands to incorporate probiotic-derived health benefits into standard liquid beverages, room-temperature capsules, and functional food products without active strain loss during shelf storage.
Neuro-nutrition is currently one of the fastest-growing market segments in North America, Europe, and Asia-Pacific. Clinical research demonstrates that specific strains (e.g., Lactobacillus plantarum PS128, Bifidobacterium longum 1714) modulate neurotransmitter synthesis including serotonin and GABA. Procurement trends show massive buyer demand for dual-action capsules combining psychobiotics with botanical adaptogens like Ashwagandha and L-Theanine.
Consumers are moving away from multi-strain broad-spectrum gut supplements in favor of tailored condition-specific solutions. Top-tier private label buyers are prioritizing formulas targeted directly at GLP-1 companion support, visceral adiposity reduction, blood glucose stabilization, vaginal microbiome balancing (L. reuteri / L. rhamnosus), and dermatological gut-skin axis health.
With the rapid expansion of global Muslim consumer demographics across Southeast Asia, the Middle East, and Western Europe, JAKIM Halal certification has shifted from an optional localized feature to an absolute prerequisite for global cross-border market entry. Furthermore, ESG compliance and SEDEX/SMETA supply chain transparency are now required by tier-1 pharmacy chains worldwide.
Navigating contract manufacturing for delicate biological supplements requires sophisticated risk-mitigation strategies. When selecting an OEM/ODM partner for high-potency probiotic capsule lines, procurement executives should evaluate factory capabilities against the following critical criteria:
Live bacterial counts decline naturally over time. Superior contract manufacturers formulate with a calculated strain overage (typically 15% to 30% above the label claim) at the time of encapsulation to guarantee declared CFU counts through the entire expiration date without relying on misleading "at time of manufacture" disclaimers.
ORIZI Group's proprietary R2B (Ready2Brand) Programme offers brand owners low minimum order quantity pathways (starting as low as RM3,000 / low batch thresholds), enabling rapid trial validation on TikTok/Shopify while seamlessly scaling to 60,000 units/day for global mass retail distribution.
Achieving rapid international cross-border compliance demands comprehensive export documentation. Our regulatory teams supply complete Certificate of Analysis (CoA), Stability Test Reports, Halal Dossiers, Free Sale Certificates (FSC), and NPRA/FDA product registration dossiers.
Find definitive, technical answers to common procurement, formulation, and manufacturing questions regarding private label probiotic capsule production.
We guarantee CFU stability through a four-stage preservation architecture: 1) Sourcing high-viability, freeze-dried (lyophilized) raw strains; 2) Formulating with precise 15–30% biological strain overages; 3) Encapsulating inside enteric, acid-resistant HPMC vegetable shells in an climate-controlled cleanroom maintained under 20% relative humidity; 4) Packaging within Alu-Alu cold-form blisters or bottles equipped with molecular desiccant technology.
We provide a full range of pharmaceutical capsule shells tailored to your target consumer base: Delayed-Release HPMC (Hydroxypropyl Methylcellulose) Vegan Capsules, Acid-Resistant Enteric Capsules, Chlorophyll-Green Vegetarian Capsules, Titanium-Free Opaque Capsules, and Halal-Certified Bovine Gelatin Capsules. All shells are available in sizes #00, #0, and #1.
Yes. Under our OEM2YOU custom manufacturing pathway, our in-house biological lab works directly with your proprietary formula specifications. We conduct compatibility matrix testing between your live strains, excipients, and active prebiotics/botanicals to prevent strain inhibition. Full Intellectual Property (IP) ownership remains strictly with your brand.
Our manufacturing sites hold official certifications including JAKIM Halal (recognized globally by MUI, JAKIM, and Gulf Halal bodies), NPRA cGMP (Current Good Manufacturing Practice), ISO 13485 (Medical Device Standard), ISO 22000, HACCP, MDA (Medical Device Authority License), and SEDEX/SMETA ethical compliance audit approval.
For ready-to-brand formulas in our R2B program, sample matching takes 1 to 2 business days, with full production completing in as fast as 1 to 2 weeks. For customized ODM/OEM probiotic formulations requiring stability validation and custom printed packaging, initial turnaround typically spans 3 to 4 weeks upon artwork sign-off.
Partner with Malaysia's most comprehensive Halal-certified, cGMP OEM contract manufacturer. Consult directly with our formulation scientists, request complimentary sample kits, or calculate bulk production pricing today.
Inquire Now